Sharon M. Watling
2011
In 2011, Sharon M. Watling earned a total compensation of $623.5K as Former Vice President Clinical Development at Vericel.
Compensation breakdown
| Non-Equity Incentive Plan | $70,000 |
|---|---|
| Option Awards | $333,179 |
| Salary | $210,625 |
| Other | $9,714 |
| Total | $623,518 |
Watling received $333.2K in option awards, accounting for 53% of the total pay in 2011.
Watling also received $70K in non-equity incentive plan, $210.6K in salary and $9.7K in other compensation.
Rankings
In 2011, Sharon M. Watling's compensation ranked 7,354th out of 10,747 executives tracked by ExecPay. In other words, Watling earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,354 out of 10,747 | 32nd |
Division Manufacturing | 2,688 out of 3,960 | 32nd |
Major group Chemicals And Allied Products | 659 out of 1,033 | 36th |
Industry group Drugs | 458 out of 781 | 41st |
Industry Biological Products, Except Diagnostic Substances | 77 out of 157 | 51st |
Source: SEC filing on October 21, 2014.
Watling's colleagues
We found three more compensation records of executives who worked with Sharon M. Watling at Vericel in 2011.